Quality nucleusQUALITY · FRAMEWORK
PIC/S GMP core principles
Ten connected controls that help a pharmaceutical quality system protect patients, product identity and reliable supply.
educational visual
SafetyQuality System
- Pharmaceutical Quality System. Put quality ownership, risk management and continual improvement at the centre of every operation. Typical evidence: Quality objectives, management review, risk registers and improvement records.
- Personnel & Responsibilities. Competent, sufficiently resourced people perform and supervise GMP activities. Typical evidence: Role profiles, qualification records, training plans and effectiveness checks.
- Premises & Equipment. Design facilities and equipment to prevent contamination, mix-ups and unintended variation. Typical evidence: Layouts, qualification, calibration, maintenance and environmental controls.
- Documentation & Data Integrity. Reliable instructions and contemporaneous records make decisions traceable and reviewable. Typical evidence: Approved procedures, controlled records, audit trails and ALCOA+ practices.
- Production & Process Control. Manufacture consistently using approved instructions, materials and in-process controls. Typical evidence: Master and batch records, line clearance, IPC results and yield reconciliation.
- Quality Control. Use suitable sampling, methods and laboratories to generate trustworthy test evidence. Typical evidence: Specifications, sampling plans, instrument records, results and OOS investigations.
- Qualification & Validation. Demonstrate that processes, systems, methods and equipment are fit for intended use. Typical evidence: Protocols, acceptance criteria, reports, continued verification and change impact.
- Outsourced Activities & Supplier Control. Keep external activities within defined responsibilities, agreements and oversight. Typical evidence: Supplier qualification, quality agreements, performance review and change control.
- Deviations, CAPA, Complaints & Recall. Detect, investigate and control failures and product-risk signals. Typical evidence: Deviation records, investigations, CAPA, complaint files and recall tests.
- Self-Inspection & Continual Improvement. Find weaknesses, determine root causes and verify that corrective actions work. Typical evidence: Audit plans, observations, root-cause analysis, CAPA and closure evidence.
Detailed explanation
What each principle is designed to achieve
This is an educational synthesis of interconnected PIC/S GMP expectations, not a verbatim official ten-item list. The applicable controls depend on product, process, site and national requirements.
01
Pharmaceutical Quality System
Align governance, objectives and lifecycle oversight so quality is designed into every decision.
Typical decision evidence: Management review, quality objectives and risk governance.
Principal risk: Fragmented or reactive quality decisions.
Back to framework02
Personnel & Responsibilities
Ensure qualified people have clear authority, responsibilities, hygiene practices and effective GMP training.
Typical decision evidence: Role profiles, training records and competency checks.
Principal risk: Errors or unauthorised decisions go undetected.
Back to framework03
Premises & Equipment
Use suitable, qualified and maintained facilities and equipment to prevent contamination, mix-ups and error.
Typical decision evidence: Qualification, calibration, maintenance and environmental controls.
Principal risk: Contamination, mix-ups or equipment failure.
Back to framework04
Documentation & Data Integrity
Keep records attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring and available as applicable.
Typical decision evidence: Controlled procedures, records and audit trails.
Principal risk: Evidence cannot support release or investigation.
Back to framework05
Production & Process Control
Execute approved processes with defined instructions, materials and in-process controls.
Typical decision evidence: Master and batch records, line clearance and IPC results.
Principal risk: Uncontrolled variation enters the batch.
Back to framework06
Quality Control
Apply appropriate sampling, specifications, testing, laboratory controls, review and release processes.
Typical decision evidence: Specifications, methods, results and OOS investigations.
Principal risk: Incorrect or unreliable disposition decisions.
Back to framework07
Qualification & Validation
Generate documented evidence that facilities, utilities, equipment, systems and processes remain fit for intended use.
Typical decision evidence: Protocols, acceptance criteria, reports and continued verification.
Principal risk: Unproven systems produce inconsistent outcomes.
Back to framework08
Outsourced Activities & Supplier Control
Define, assess, approve and oversee contractors and suppliers through risk-based responsibilities and controls.
Typical decision evidence: Qualification, quality agreements and performance review.
Principal risk: External variability remains hidden.
Back to framework09
Deviations, CAPA, Complaints & Recall
Investigate failures and product-risk signals, address root causes and maintain effective recall capability.
Typical decision evidence: Deviation files, CAPA, complaints and recall tests.
Principal risk: Recurring failures or unsafe product remain uncontrolled.
Back to framework10
Self-Inspection & Continual Improvement
Evaluate GMP effectiveness, monitor trends and drive sustainable improvement of the quality system.
Typical decision evidence: Audit plans, trend reviews and CAPA effectiveness evidence.
Principal risk: Weak signals are missed until they become failures.
Back to frameworkKey takeaways
Five ideas to carry into practice
- Quality is designed into processes and controls; end-product testing alone cannot create quality.
- Management responsibility gives the Pharmaceutical Quality System authority, resources and direction.
- Controlled documentation and trustworthy data provide the evidence needed for sound decisions.
- Qualification, validation and change management support lifecycle control as processes evolve.
- Deviations, CAPA, complaints, self-inspection and trend analysis turn learning into continual improvement.
Authoritative references
Verify the current requirements.
This educational overview does not replace current PIC/S, WHO, ICH, DRAP, ISO, national legal, product-specific or market-specific requirements.
Related MHPL solutions